BioSpace News Archive

The Sabin Vaccine Institute (Sabin) announced today that it has awarded grants to research teams in four countries to explore the social drivers of COVID-19 misinformation, and its impact on routine immunization acceptance and the acceptance of a COVID-19 vaccine.

Rafael Pharmaceuticals , Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced that Sanjeev Luther, President and Chief Executive Officer, will present at the virtual 39th Annual J.P. Morgan Healthcare Conference , on Thursday, Jan. 14. Mr. Luther will discuss the status of the Company and milestones it met throughout the year, including receiving two FDA-granted Fast Track d

Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2020 financial results ahead of its participation at the 39th Annual JP Morgan Healthcare Conference on January 11-14, 2021.

ignify Health, a leading healthcare platform leveraging advanced analytics, technology and nationwide healthcare networks to create and power value-based programs, is offering a suite of Clinical Support Services and Caregiver Support Services to reduce clinical and social barriers to therapy initiation and adherence.

Today, the Cystic Fibrosis Foundation announced a new award of up to $2 million to Eloxx Pharmaceuticals Inc. to support the global Phase 2 clinical program of ELX-02, a potential therapy to treat people with cystic fibrosis who have nonsense mutations.

Total prescriptions of GOCOVRI of approximately 8,165 for fourth quarter 2020 and approximately 31,070* for full year 2020

Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced today that it has met all specifications and passed all of the final release tests for its first scaled-up clinical-grade manufacturing run of REQORSA™ immunogene therapy,

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today positive preliminary data from the Federally listed clinical trial “Correlation of Campbell Score with Suicidal Ideation."1

Bioclinica, an integrated solutions provider of clinical life science and technology expertise, today announced its partnership with IKCON PHARMA (subsidiary/affiliate of IKCON TECHNOLOGIES INC), a Clinical Research Organization (CRO) & technology services company

HM Health Solutions (HMHS), a wholly-owned subsidiary of Highmark Health focused on delivering business solutions to health insurers has named Brian Lucotch as its new Chief Operating Officer (COO), effective Monday, January 18, 2021.